494 related articles for article (PubMed ID: 7817735)
1. Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration. A patient-centered, partially randomised prospective study.
Henshaw R; Naji S; Russell I; Templeton A
Acta Obstet Gynecol Scand; 1994 Nov; 73(10):812-8. PubMed ID: 7817735
[TBL] [Abstract][Full Text] [Related]
2. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.
Henshaw RC; Naji SA; Russell IT; Templeton AA
BMJ; 1993 Sep; 307(6906):714-7. PubMed ID: 8401094
[TBL] [Abstract][Full Text] [Related]
3. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae.
Henshaw RC; Naji SA; Russell IT; Templeton AA
Hum Reprod; 1994 Nov; 9(11):2167-72. PubMed ID: 7868693
[TBL] [Abstract][Full Text] [Related]
4. Induction of abortion in early pregnancy with mifepristone in conjunction with gemeprost.
Somell C; Olund A
Acta Obstet Gynecol Scand; 1993 Jan; 72(1):39-42. PubMed ID: 8382430
[TBL] [Abstract][Full Text] [Related]
5. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486).
Henshaw RC; Templeton AA
Br J Obstet Gynaecol; 1991 Oct; 98(10):1025-30. PubMed ID: 1751434
[TBL] [Abstract][Full Text] [Related]
6. Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost.
Norman JE; Thong KJ; Rodger MW; Baird DT
Br J Obstet Gynaecol; 1992 Jul; 99(7):601-6. PubMed ID: 1525104
[TBL] [Abstract][Full Text] [Related]
7. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial.
Howie FL; Henshaw RC; Naji SA; Russell IT; Templeton AA
Br J Obstet Gynaecol; 1997 Jul; 104(7):829-33. PubMed ID: 9236649
[TBL] [Abstract][Full Text] [Related]
8. A randomised study of two doses of gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
Thong KJ; Lynch P; Baird DT
Contraception; 1996 Aug; 54(2):97-100. PubMed ID: 8842586
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
Baird DT; Sukcharoen N; Thong KJ
Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
Rodger MW; Baird DT
Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
[TBL] [Abstract][Full Text] [Related]
11. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
Rodger MW; Baird DT
Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
[TBL] [Abstract][Full Text] [Related]
12. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
el-Refaey H; Hinshaw K; Templeton A
Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
[TBL] [Abstract][Full Text] [Related]
13. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh.
Cameron ST; Glasier AF; Logan J; Benton L; Baird DT
Br J Obstet Gynaecol; 1996 Dec; 103(12):1222-9. PubMed ID: 8968240
[TBL] [Abstract][Full Text] [Related]
14. Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) or the antiprogestogen RU 486.
Cameron IT; Baird DT
Br J Obstet Gynaecol; 1988 Mar; 95(3):271-6. PubMed ID: 3370199
[TBL] [Abstract][Full Text] [Related]
15. Induction of second trimester abortion with mifepristone and gemeprost.
Thong KJ; Baird DT
Br J Obstet Gynaecol; 1993 Aug; 100(8):758-61. PubMed ID: 8399016
[TBL] [Abstract][Full Text] [Related]
16. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.
Ulmann A; Silvestre L; Chemama L; Rezvani Y; Renault M; Aguillaume CJ; Baulieu EE
Acta Obstet Gynecol Scand; 1992 May; 71(4):278-83. PubMed ID: 1322621
[TBL] [Abstract][Full Text] [Related]
17. Changes in the concentration of alpha-fetoprotein and placental hormones following two methods of medical abortion in early pregnancy.
Thong KJ; Norman JE; Baird DT
Br J Obstet Gynaecol; 1993 Dec; 100(12):1111-4. PubMed ID: 7507707
[TBL] [Abstract][Full Text] [Related]
18. Oral misoprostol versus vaginal gemeprost for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestation.
Ngai SW; Yeung KC; Lao T; Ho PC
Contraception; 1995 Jun; 51(6):347-50. PubMed ID: 7554974
[TBL] [Abstract][Full Text] [Related]
19. Termination of early human pregnancy with either 50 mg or 200 mg single oral dose of mifepristone (RU486) in combination with either 0.5 mg or 1.0 mg vaginal gemeprost.
Prasad RN; Choolani M
Aust N Z J Obstet Gynaecol; 1996 Feb; 36(1):20-3. PubMed ID: 8775244
[TBL] [Abstract][Full Text] [Related]
20. Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion.
Urquhart DR; Templeton AA
Br J Obstet Gynaecol; 1991 Apr; 98(4):396-9. PubMed ID: 2031899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
